Founded in Germany in 1839  and with over 56,000 employees in 64 countries, B. Braun is one of the world's largest medical technology companies, specializing in solutions related to infusion therapy, orthopaedics, neurosurgery, anaesthesia, extracorporeal blood treatment, spine surgery, diabetes care, clinical nutrition, wound management, infection prevention and surgical technologies. Through constructive dialogue, B. Braun develops high quality product systems and services that are both evolving and progressive - and in turn, improves people's health around the world. In 2015, the Group generated sales of approximately €6.13 billion. In Asia Pacific, B. Braun's strong presence is established through over 15,500 employees, 10 production sites and business offices in every key Asia Pacific market.  The regional headquarters of B. Braun Asia Pacific is located in Penang, Malaysia, together with one of the   B. Braun’s largest production sites with more than 7,500 employees and 5 manufacturing plants, which produces healthcare products for global markets.

 Reconstructive Surgery & Anaplastology,Tropical Medicine & Surgery,Surgery: Current Research,Journal of Surgery